© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
May 31, 2017
With the global epidemic of obesity showing no signs of waning, physicians should be aware of the cardiac side effects of weight-loss drugs.
MD Magazine® Peer Exchange® recently hosted an esteemed panel in which the topic of discussion was taking the personalized approach in type 2 diabetes management.
Researchers have been investigating whether PCSK9 inhibitors can protect other patients at high risk for a cardiovascular event.
Jennifer Green, MD: Outcomes, Impact of SGLT2i, GLP-1 RA Combination Therapy
Joshua J. Joseph, MD: Managing CV Risk Factors in Patients with Type 2 Diabetes
Encapsulated Benzoyl Peroxide Cream, Tretinoin Combination Effectively & Safely Treats Acne